1. Home
  2. GLU vs MDXH Comparison

GLU vs MDXH Comparison

Compare GLU & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLU
  • MDXH
  • Stock Information
  • Founded
  • GLU 2004
  • MDXH 2003
  • Country
  • GLU United States
  • MDXH Belgium
  • Employees
  • GLU N/A
  • MDXH N/A
  • Industry
  • GLU Finance/Investors Services
  • MDXH
  • Sector
  • GLU Finance
  • MDXH
  • Exchange
  • GLU Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • GLU 92.2M
  • MDXH 93.1M
  • IPO Year
  • GLU N/A
  • MDXH 2021
  • Fundamental
  • Price
  • GLU $15.56
  • MDXH $1.86
  • Analyst Decision
  • GLU
  • MDXH Strong Buy
  • Analyst Count
  • GLU 0
  • MDXH 2
  • Target Price
  • GLU N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • GLU 12.4K
  • MDXH 112.7K
  • Earning Date
  • GLU 01-01-0001
  • MDXH 02-26-2025
  • Dividend Yield
  • GLU 8.60%
  • MDXH N/A
  • EPS Growth
  • GLU N/A
  • MDXH N/A
  • EPS
  • GLU 0.62
  • MDXH N/A
  • Revenue
  • GLU N/A
  • MDXH $84,708,000.00
  • Revenue This Year
  • GLU N/A
  • MDXH $28.76
  • Revenue Next Year
  • GLU N/A
  • MDXH $19.91
  • P/E Ratio
  • GLU $22.50
  • MDXH N/A
  • Revenue Growth
  • GLU N/A
  • MDXH 33.01
  • 52 Week Low
  • GLU $11.61
  • MDXH $1.55
  • 52 Week High
  • GLU $15.40
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • GLU 57.11
  • MDXH 33.28
  • Support Level
  • GLU $15.40
  • MDXH $1.80
  • Resistance Level
  • GLU $15.68
  • MDXH $1.97
  • Average True Range (ATR)
  • GLU 0.31
  • MDXH 0.07
  • MACD
  • GLU 0.10
  • MDXH -0.01
  • Stochastic Oscillator
  • GLU 86.79
  • MDXH 12.50

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: